Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas

Annals of Neurology

Volumn 42, Issue 2, 1997, Pages 230-235

  Wienecke, Ralf ^a   Guha, Abhijit ^d   Maize Jr , John C ^a   Heideman, Richard L ^b   DeClue, Jeffrey E ^a   Gutmann, David H ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b St Jude Children's Research   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; EPENDYMOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGE FACTORS; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; DNA PRIMERS; EPENDYMOMA; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; POLYMERASE CHAIN REACTION; PROTEIN BIOSYNTHESIS; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0030854102     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420215     Document Type: Article

References (28)

1. Knudson A. Antioncogenes and human cancer. Proc Natl Acad Sci USA 1993;90:10914-10921
2. Knudson AG. Mutation and cancer: statistical study of retino-blastoma. Proc Natl Acad Sci USA 1971;68:820-823
3. Gomez MR. Tuberous sclerosis. 2nd ed. New York: Raven Press, 1988
4. Jansen LAJ, Pove S, Atwood J, et al. A comparative study on genetic heterozygosity in tuberous sclerosis: evidence for one gene on 9p34 and a second on 11q22-23. Ann NY Acad Sci 1991;615:306-315
5. Haines JL, Short MP, Kwiatkowski DJ, et al. Localization of one gene for tuberous sclerosis within 9q32-34 and further evidence for heterogeneity. Am J Hum Genet 1991;49:764-772
6. European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993;75:1305-1315
7. Wienecke R, Konig A, DeClue JE. Identification of tuberin, the tuberous sclerosis-2 product: tuberin possesses specific Rap1GAP activity. J Biol Chem 1995;270:16409-16414
8. Geist RT, Reddy AJ, Zhang J, Gutmann DH. Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues. Neutobiol Dis 1996;3:111-120
9. Martin GA, Viskochil D, Bollag G, et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990;63:843-849
10. Ballester R, Marchuk DA, Boguski M, et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 1990;63:851-859
11. Xu G, Lin B, Tanaka K, et al. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 1990;63: 835-841
12. Xu G, O'Connell P, Viskochil D, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990;62: 599-608
13. Jin F, Wienecke R, Xiao G-H, et al. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Proc Natl Acad Sci USA 1996;93:9154-9159
14. Geist RT, Gutmann DH. The tuberous sclerosis 2 gene is expressed at high levels in the adult cerebellum and developing spinal cord. Cell Growth Differ 1995;6:1477-1483
15. Wienecke R, Maize JC Jr, Shoarinejad F, et al. Co-localization of the TSC2 product, tuberin, with its target Rap1 in the Golgi apparatus. Oncogene 1996;13:913-923
16. Wienecke R, Maize JC Jr, Reed J, et al. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Am J Pathol 1997;150:43-50
17. Kerfoot C, Wienecke R, Meniche M, et al. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Brain Pathol 1997 (in press)
18. Rubinfeld B, Munemitsu S, Clark R, et al. Molecular cloning of a GTPase activating protein specific for the Krev-1 protein, p21-rap1. Cell 1991;65:1033-1042
19. Yoshida Y, Kawata M, Miura Y, et al. Microinjection of smg/ rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes. Mol Cell Biol 1992;12:3407-3414
20. Xiao G-H, Jin F, Yeung RS. Identification of tuberous sclerosis 2 messenger RNA splice variants that are conserved and differentially expressed in rat and human tissues. Cell Growth Differ 1995;6:1185-1191
21. Xu L, Sterner C, Maheshwar MM, et al. Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues. Genomics 1995;27:475-480
22. Riccardi VM. Neurofibromatosis: past, present and future. N Engl J Med 1991;324:1283-1285
23. Evans DGR, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med 1992;304:603-618
24. Gutmann DH, Geist RT, Rose K, et al. Loss of neurofibromatosis type 1 (NF1) gene expression in pheochromocytomas from patients without NF1. Genes Chromosomes Cancer 1995;13: 104-109
25. Gutmann DH, Cole JL, Stone WJ, et al. Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type 1. Genes Chromosomes Cancer 1993;10:55-58
26. Sainz J, Huynh DP, Figueroa K, et al. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 1994;3:885-891
27. Ruttledge MH, Sarrazin J, Rangaratnam S, et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 1994;6:180-184
28. Mizuguchi M, Kato M, Yamanouchi H, et al. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Ann Neurol 1996;40:941-944